8
Platelet count in healthy subjects treated with antiplatelet drugs
Authors: Maczy González-Rincón; Melvis Arteaga-Vizcaino; Ana Ruíz; Olga Briceño; Maribel Quintero; Jesús Quintero; José Ramón Urdaneta

Number of views: 397
Platelet count in peripheral blood of healthy subjects with antiplatelet drugs. 20 subjects were analized. They were
distributed in two groups: subject A: 10 who received aspirin (100 mg) and B:10 with Clopidogrel (75 mg) for 7
days. In all subjects studied platelet count in peripheral blood and PRP. It found a platelet count before treatment
with antiplatelet agents in peripheral blood of 258,6 ± 54,46 x 109
l and 7 days after 254 ± 41,86 x 109
l (aspirin)
and 285,4 ± 70, 196,5 ± 37,90 x 109
l (Clopidogrel) respectively. In the PRP of subjects before receiving aspirin was
486,5 ± 129,54 x 109
l and after 449,2 ± 85,51 x 109
l; prior to Clopidogrel ingestion was 565,2 ± 150,41 and 592,9
± 203,46 x 109
l after treatment. Significant differences were found only for the platelet count in the Clopidogrel
Group (p < 0.05). A significant decrease in platelet count was observed in peripheral blood after administration
of Clopidogrel, possibly as a result of its pharmacological mechanism. More studies are needed to assess a greater
number of individuals and better measure the effect of antiplatelet agents